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The Contribution of CLIP2 Haploinsufficiency
to the Clinical Manifestations of the Williams-Beuren Syndrome
Geert Vandeweyer,1 Nathalie Van der Aa,1 Edwin Reyniers,1 and R. Frank Kooy1,*
Williams-Beuren syndrome is a rare contiguous gene syndrome, characterized by intellectual disability, facial dysmorphisms, connec-
tive-tissue abnormalities, cardiac defects, structural brain abnormalities, and transient infantile hypercalcemia. Genes lying telomeric
to RFC2, including CLIP2, GTF2I and GTF2IRD1, are currently thought to be the most likely major contributors to the typical Williams
syndrome cognitive profile, characterized by a better-than-expected auditory rote-memory ability, a relative sparing of language capa-
bilities, and a severe visual-spatial constructive impairment. Atypical deletions in the region have helped to establish genotype-pheno-
type correlations. So far, however, hardly any deletions affecting only a single gene in the disease region have been described.We present
here two healthy siblings with a pure, hemizygous deletion of CLIP2. A putative role in the cognitive and behavioral abnormalities seen
in Williams-Beuren patients has been suggested for this gene on the basis of observations in a knock-out mouse model. The presented
siblings did not show any of the clinical features associated with the syndrome. Cognitive testing showed an average IQ for both and no
indication of theWilliams syndrome cognitive profile. This shows thatCLIP2 haploinsufficiency by itself does not lead to the physical or
cognitive characteristics of theWilliams-Beuren syndrome, nor does it lead to theWilliams syndrome cognitive profile. Although contri-
bution of CLIP2 to the phenotype cannot be excluded when it is deleted in combination with other genes, our results support the
hypothesis that GTF2IRD1 and GTF2I are the main genes causing the cognitive defects associated with Williams-Beuren syndrome.Williams-Beuren syndrome (WBS [MIM 194050]) is a rare
neurodevelopmental disorder with an estimated frequency
of 1/7,500 to 1/15,000. The WBS phenotype includes
recognizable facial dysmorphisms, connective tissue
abnormalities, cardiac defects (SVAS/PPS), structural brain
abnormalities, transient infantile hypercalcemia, and
a specific cognitive profile.1–3 Independent of the global
IQ level, which is commonly in the mild range of intellec-
tual disability, the Williams syndrome cognitive profile
(WSCP) is globally characterized by a better-than-expected
auditory rote memory ability, relatively spared language
capabilities, and a severe visual-spatial constructive impair-
ment.4 The WSCP has been divided into sub-profiles
involving severe impairments in visual-spatial processing
and better skills in the verbal domain. It has further been
demonstrated that specific defects exist in the working
memory of WBS patients; these defects relate to both the
verbal and spatial domains when patients need to process
stored information.5 Although the four indices of the
Wechsler intelligence testing (verbal comprehension,
working memory, perceptual organization, and processing
speed) specifically query discrete cognitive domains,
cognitive profiling of WBS patients typically reveals sub-
index differences on the individual subtest scores. Specifi-
cally, the WSCP translates to significantly higher scores on
the vocabulary and similarities subtests of the verbal
comprehension index, as well as to significantly lower
scores on arithmetic, digit-symbol, and block-design
subtests from the working-memory, processing-speed,
and perceptual-organization tests, respectively. Despite
the global impairment in working memory, WBS patients1Department of Medical Genetics, University Hospital of Antwerp, University
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span subtest.4–8
The causative microdeletion is commonly 1.45 Mb and
comprises 28 genes on 7q11.23. The deleted region is
delineated by low-copy repeats of high sequence similarity,
facilitating genomic rearrangement by means of nonallelic
homologous recombination (NAHR).9,10 The reciprocal
7q11.23 microduplication causes the Sommerville-Van
der Aa syndrome (MIM 609757), characterized by mild
but distinct facial dysmorphisms and cognitive abnormal-
ities, the most notable of which is a severe language
delay.11–13 Because the phenotype of the microduplication
mirrors that of the microdeletion in some aspects, it has
been speculated that specific genes in the 7q11.23 region
are very sensitive to dosage alterations that might affect
human language and visual-spatial abilities.12
The study of rare atypical deletion patients suggested
that genes telomeric to RFC2 (MIM 600404), including
CLIP2 (MIM 603432), GTF2I (MIM 601679) and GTF2IRD1
(MIM 604318), are most likely responsible for the typical
WSCP and social behavior of WBS patients.1,14–19 Based
on studies in mouse and fruit fly models, hypotheses of
association between specific aspects of theWBS phenotype
and individual genes, such as ELN (MIM 130160) for the
cardiac and connective-tissue defects,20 GTF2IRD1 and
BAZ1B (MIM 605681) for craniofacial features,15,21 and
STX1A (MIM 186590) and MLXIPL (MIM 605678) for dia-
betes mellitus,22,23 were formulated. Both GTF2IRD1 and
CLIP2 were linked to the neurological and cognitive
symptoms.24–26 Of these genes, ELN is the only one whose
role has been confirmed so far by detection of pointof Antwerp, Prins Boudewijnlaan 43, 2650 Edegem, Belgium
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Figure 1. Well-Characterized, Reported Atypical Deletions in the WBS Critical Region
Deletions (in red) relevant to this study are shown. DNA from the individuals presented here was isolated from peripheral blood after
informed consent was obtained. Segmental duplications flanking the WBS critical region are indicated by black arrows. Affected genes
and cognitive details, if available, are listed on the right.mutations and single-gene deletions in patients with iso-
lated SVAS.27–29
We present a pure, hemizygous CLIP2 deletion in two
unaffected siblings. The intragenic deletion was initially
identified as a supplementary finding in a patient referred
to our department on indication of global developmental
delay and microcephaly. As a toddler, he was diagnosed
with autism on the basis of repetitive behavior, poor
interaction skills, and hand flapping. Psycho-diagnostic
evaluation at the age of 15 years showed a total IQ of 69
(WISC-R). In late adolescence he developed visual as well
as auditory hallucinations and was diagnosed with schizo-
phrenia. Dysmorphic features, apart from microcephaly,
included long palpebral fissures, a high nasal bridge, and
a prominent inverted lower lip. We detected a 580 kb
microduplication at 16p11.2 (MIM 611913) by using an
Illumina HumanCNV370-Quad BeadChip. The clinical
presentation of this patient fits well within the described
phenotype of carriers of a 16p11.2 microduplication. The
phenotype of the patient is thus fully explained by the
de novo 16p11.2 microduplication.30,31
With the approval of the institutional ethics committee,
the patients’ DNA was included in a follow-up research
cohort. Refined data analysis with CNV-WebStore identi-
fied an additional deletion, ranging from position
73,760,704 to 73,810,096, of five consecutive probes in
CLIP2 on chromosome 7q11.23.32 The deletion was
confirmed by reanalysis on an Illumina HumanCyto12-
v1.0 BeadChip. On the basis of the higher coverage of 19
consecutive probes in this disease-associated region, the
deletion was predicted to range from position 73,734,542
to 73,815,967. MLPA analysis showed that the CLIP2 dele-
tion was also present in the unaffected mother and her
brother, referred to as ‘‘healthy siblings,’’ whereas the
duplication of 16p11.2 in the autistic patient appeared
de novo.33 PCR primers spanning the deletion were de-
signed, allowing characterization of the breakpoints at
the nucleotide level. The deleted region spanned 83 kb,
ranging from position 73,740,492 to 73,823,520 (NCBI
GRCh37). The proximal breakpoint is located in intron 2
of CLIP2, and the distal breakpoint maps in the intergenic1072 The American Journal of Human Genetics 90, 1071–1078, Juneregion between CLIP2 and GTF2IRD1 (Figure 1). Both
breakpoints were located in AluSz repeats as identified by
RepeatMasker (Figure 2).34 Locally aligning these elements
by using LALIGN showed more than 82% similarity
between the flanking repeats and 26 base pairs of perfect
identity at the breakpoints, indicating Alu-mediated,
unequal homologous recombination as the causative
mechanism for the rearrangement.35,36
Expression of theCLIP2,CLIP1, GTF2IRD1, GTF2I, LAT2,
RFC2, STX1A, andWBSCR22 genes was examined by qPCR
on lymphoblastoid cell lines with GAPDH, YWAZ, and
HPRT as reference genes (Figure 3). A set of 15 cognitively
tested individuals of normal intelligence was used as
a control. Because no lymphoblastoid material was avail-
able from the male sibling, two replicate cDNA syntheses
from two independent cell lines of the female sibling
were used as test samples. A significant reduction of
CLIP2 expression to about 40% residual expression was de-
tected (p < 0.001). No evidence of a compensation effect
by CLIP1 overexpression was found. No significant alter-
ations in the expression of GTF2I, LAT2, RFC2, STX1A, or
WBSCR22 was detected, but the expression of GTF2IRD1,
located 48 kb 30 of CLIP2, was significantly increased (p
< 0.001) in comparison to the normal controls. These
results are in line with studies in full-deletion WBS
patients, demonstrating that the expression of most candi-
date genes, including CLIP2, is reduced to 50% of the level
observed in controls when this expression is analyzed in
lymphoblast cell lines.37–39 In contrast, no reduction in
GTF2IRD1 expression is observed in this cell type for
typical WBS patients, presumably as a consequence of
a negative autoregulation mechanism.18,19,40 In fibroblast
cell lines, however, the expression of GTF2IRD1 is reduced,
indicating tissue-specific regulation.39 Due to this tissue-
dependent regulation, the relevance of the observed over-
expression ofGTF2IRD1 in blood cells of the female sibling
is unclear, and expression might be differently affected in
the central nervous system.
Both siblings with the pure CLIP2 deletion are healthy
adults of European descent in their fifties with an unre-
markable medical, developmental, and academic history.8, 2012
Figure 2. AluSz Alignment wth the LALIGN Program
Breakpoint position is indicated by a red rectangle around the flanking nucleotides. Proximal AluSz coordinates: chr7:73,740,287–
73,740,582 with the breakpoint at position 73,740,492. Distal AluSx coordinates: chr7:73,823,314–73,823,618 with the breakpoint at
position 73,823,520.The woman has worked as a solicitor’s secretary for the last
25 years, and her brother is a librarian. Both of them are
married and have children. Contrary to adults with the
WBS, they have a normal body habitus and an average
proportional stature.41 There is no hearing impairment,
there are no signs of cardiovascular disease or hyperten-
sion, and there is no history of gastrointestinal problems
or diabetes. On physical examination, there is no scoliosis
and no stiffness or hypermobility in the joints. There is no
premature greying of the hair or sagging of the cheeks, as
seen in adults with WBS. The typical dysmorphic features
of WBS in adults are a wide mouth and prominent lips
together with prominence of the supra orbital ridges and
a narrow nasal root, and these features were not present
in the siblings. Neurological examination in the female
sibling showed slight divergent strabismus of the right
eye and a weakness in focalization, leading to a suspicion
of amblyopia. This was not confirmed by an ophthalmolo-
gist. Examination of ocular motility was otherwise normal.
Cranial nerve evaluation showed no abnormalities. Periph-
eral motor and sensibility evaluation as well as reflexes
were all normal. Coordination, gait, and equilibrium
were normal. She has no history of psychiatric signs or
symptoms. Psychiatric evaluation did not reveal any signs
of comorbid behavioral or the mental-health problems,
such as generalized anxiety, attention-deficit hyperactivity
disorder, depression, and phobias and obsessions, that are
seen in WBS patients.41,42 The brother has no obvious
neurological or psychiatric abnormalities, but thorough
examination by a neurologist was not performed.
Both siblings were subjected to formal cognitive testing
with Wechsler Adult Intelligence Scales (WAIS-III, The
Psychological Corporation, 1997). Verbal IQ was scored
by seven tests: vocabulary, similarities, calculating, series
of numbers, information, understanding, and repeating
of numbers and letters. Five tests were used for perfor-
mance IQ testing: symbol substitution, picture arrange-
ment, matrix reasoning, object assembly, and block design.
The majority of adult WBS patients score in the mild range
of intellectual disability (55 to 69 IQ points) on standard-
ized intelligence tests and have a slightly higher VIQThe Americthan PIQ score, although this difference is not significant
in most cases.7 It can be appreciated from Figure 4 and
Table 1 that the siblings’ obtained IQ scores closely
resemble a normal cognitive profile. Both siblings per-
formed on an average to above-average level on the
different indices. The brother’s verbal IQ was 5 points
higher than performance IQ, and the sister’s verbal IQ
was 6 points lower. Thus, the siblings showed small but
non-significant and reciprocal differences between verbal
and performance IQ. The four secondary indices of the
WAIS-III (verbal comprehension, working memory,
perceptual organization, and processing speed) were also
scored so that maximum information on the cognitive
strengths and weaknesses of the patients would be avail-
able. No evidence for a relative verbal strength was present
at this level either. The brother did not show any signifi-
cant differences between the individual index scores,
whereas the sister showed significant relative strengths in
working memory and processing speed, contributing to
verbal and performance IQ scores, respectively.
In addition to a mild global intellectual disability and
a slightly elevated VIQ/PIQ ratio, significant differences
between individual subtests are highly indicative of the
WSCP. WBS patients typically have low arithmetic, digit-
symbol, and block-design scores, whereas scores on vocab-
ulary similarities and digit span are higher. A tendency to
higher object-assembly and matrix-reasoning scores has
also been observed.4,6–8 Individual subtest scores for these
siblings (see Figure 5 and Table 2) did not reveal the
described common pattern of strengths and weaknesses
as seen in WBS patients. Both siblings had normal to
high scores on all subtests and no significant deviations
from the reference values. The highest score for both was
on digit span. Although performance on this subtest is
typically a relative strength of WBS patients, we feel we
cannot attribute this to the CLIP2 deletion because the
strength in digit span might be merely a consequence of
training during the siblings’ daily habits and occupation.
None of the other significant deviations in subtest scores,
where these are shared by both siblings, are indicative of
the WSCP. Furthermore, the sister has a significant relativean Journal of Human Genetics 90, 1071–1078, June 8, 2012 1073
Figure 3. Results of Gene-Expression Study
Relative gene-expression levels (RELs) of CLIP2, CLIP1, GTF2IRD1, GTF2I, STX1A, RFC2, WBSCR22, and LAT2 in lymphoblastoid cell
lines from 15 independent control samples and four samples from the female carrier. Isolation of total RNA, cDNA synthesis, and RT-PCR
normalization and analysis were performed as described before.1 CLIP2a and CLIP2b represent two distinct probesets targeting different
exons of CLIP2 within the deleted region. The four carrier samples represent two cDNA syntheses from RNA isolated from two indepen-
dent cell cultures of the same individual. ***p < 0.001, Mann-Whitney U test.strength in digit symbol coding, and her brother scores
poorly in vocabulary, both contrary to the results typical
for the WSCP. Finally, no evidence for the visual-spatial
impairment seen inWBS patients was present in the scores
for the block-design subtest.
These results demonstrate that CLIP2 haploinsufficiency
by itself might not be critical to the pathology and cogni-
tive profile of WBS. This contrasts with the suggested
involvement of CLIP2 in the clinical manifestation of the
syndrome in earlier functional and animal studies. CLIP21074 The American Journal of Human Genetics 90, 1071–1078, Junecodes for the CAP-GLY-domain-containing linker protein
2 (CLIP-115). The protein colocalizes with CLIP-170, en-
coded by CLIP2 paralog CLIP1, at the plus ends of growing
microtubules along with other so-called microtubule-plus-
end tracking proteins (þTIPS). These proteins regulate the
polymerization of the microtubule network to form the
actin skeleton, and it has been hypothesized that deregula-
tion of this process might underlie the clinical presenta-
tion of Williams-Beuren Syndrome.43,44 Two lines of
evidence support this hypothesis. First, mutations inþTIPs8, 2012
Figure 4. Cognitive Profiles Associated with the Reported Deletions in Figure 1, for those Cases where FSIQ, VIQ, and PIQWas Avail-
able
Howlin et al. (2010) represents typical WBS patients who were at least 40 years old and were tested with WAIS-III. Expected IQ values in
control populations are 100. *CLIP2 was not deleted but had lowered expression.other than CLIP-115 and CLIP-170 cause neurological
disorders such as lissencephaly (PAFAH1B1 [MIM
601545]) and amyotrophic lateral sclerosis (DCTN1 [MIM
105400]).45,46 Second, mice heterozygous for Clip2 showed
phenotypic traits compatible with the characteristic abnor-
malities seen in WBS patients, including mild structural
brain abnormalities and growth retardation. Furthermore,
disturbed hippocampal functioning, correlating with the
visual-spatial impairment of WBS patients,25,26 was
observed.
However, the role of CLIP2 in the WBS phenotype was
only partially supported by studies of atypical deletions
in patients because these studies provided evidence both
for and against a role for CLIP2 in various aspects of the
phenotype on the basis of cognitive and physical charac-
teristics (see Figure 1). Antonell et al.18 presented two fami-
lies whose members had deletions in the WBS region,
slightly lower cognitive performance, and mild facial dys-Table 1. WAIS-III Results of the Cognitive Profiling in Both
Deletion Carriers
Female Carrier Male Carrier
Global IQ 107 105
Performal IQ 111 103
Verbal IQ 105 107
Verbal comprehension
index (VCI)
103 105
Perceptual organisationindex
(POI)
99 107
Working memory index
(WMI)
122 114
Processing speed index (PSI) 123 103
Significant differences WMI and PSI
versus VCI and PRI
none
Formal cognitive testing was performed by a trained psychologist. The signif-
icance threshold was taken from the WAIS III NL Technische Handleiding (Pear-
son, Amsterdam, The Netherlands). Significant deviations between secondary
indices and verbal or performance IQ are defined as deviations seen in less than
5% from the standardized sample used for calibration of the test.
The Americmorphisms but who lacked the WSCP. CLIP2 expression
was affected in both families, whereas GTF2I expression
was not. It was thus hypothesized that CLIP2 might
contribute to some of the general aspects of WBS but
that hemizygosity of GTF2I and GTF2IRD1 was necessary
for the typical WSCP and also greatly affected the
complete phenotype. Two atypical deletions previously
described by Hirota et al.47 support this hypothesis. The
first deletion included CLIP2, and the second spanned
only EIF4H and just spared CLIP2. Both deletions shared
the typical centromeric breakpoint. Both carriers had
a similar full-scale IQ in the mild intellectual-disability
range (FSIQ ¼ 64/65) and partially lacked the WSCP char-
acteristics, thus implicating GTF2I and GTF2IRD1 haploin-
sufficiency in the WSCP. It was noted by the authors that
the VIQ/PIQ ratio of 64/72 for the first case is exceptional
and in fact opposed to what is expected for the WSCP. Tas-
sabehji et al.15 reported a patient with a deletion that went
from the typical centromeric breakpoint to GTF2IRD1 and
included CLIP2. This patient had typical but mild
syndrome-typical features, such as spatial-cognition
defects and facial characteristics suggestive of WBS. In
combination with results from GTF2IRD1 and CLIP2
mouse models, these findings led to the postulation that
CLIP2 was involved in the observed mild neurological
phenotype in this patient, and the craniofacial abnormal-
ities were attributed to GTF2IRD1. Haploinsufficiency of
GTF2I was proposed to be necessary for the full WBS
phenotype. Dai et al.48 reported on an individual who
had an atypical deletion sparing only GTF2I and presented
with a milder phenotype but had some of the typical
WSCP traits, including visual-spatial impairment and
a high VIQ/PIQ ratio. The authors postulated that GTF2I
is most likely implicated in the hypersocial phenotype
and general cognitive defects of WBS, whereas GTF2IRD1
is responsible for the visual-spatial defects of the WSCP.
This hypothesis was further supported by the family pre-
sented by Morris et al.49 because the carriers of the dele-
tion, affecting GTF2IRD1 but sparing GTF2I, had normal
intelligence levels and fit the WSCP. However, Ferreroan Journal of Human Genetics 90, 1071–1078, June 8, 2012 1075
Figure 5. Individual WAIS-III Subtest Scores
Howlin et al. (2010), 40þ represents typical WBS patients who were at least 40 years old when they were tested with WAIS-III. All scores
are age-corrected scaled scores. Normal results are indicated by a gray area (mean 10, sd 3).et al.17 recently reported on a patient with a deletion span-
ning a region from BAZ1B to CLIP2. The patient showed
a normal full-scale IQ, signs of the WSCP, and a high
VIQ/PIQ ratio, indicating a role for CLIP2, rather than
GTF2IRD1, in the WSCP. These findings are compatible
with the deletions reported by Dai et al. and MorrisTable 2. Summary of Results from WAIS-III Individual Subtests for bo
Female Carrier
Age-Corrected
Scaled Score
Deviation from
Own Average**
Strengths and
Weaknesses
Verbal IQ Subtests
Vocabulary 10 1.86
Similarities 10 1.86
Arithmetic 8 3.86 weakness
Digit span 16 þ4.14 strength
Information 12 þ0.14
Comprehension 10 1.86
Letter-number
Sequencing
17 þ5.14 strength
Performance IQ Subtest
Picture completion 8 3.8 weakness
Digit symbol 15 þ3.2 strength
Block design 10 1.8
Matrix reasoning 12 þ0.2
Picture arrangement 14 þ2.2 1
Symbol search 13 þ1.2 1
**Averages of verbal and performance subtests are 11.86 and 11.8. ***Averages of
in sections 1 and 2 of the Supplemental Data. Testing was performed as summar
1076 The American Journal of Human Genetics 90, 1071–1078, Juneet al., both including CLIP2 and both found in individuals
who showed signs of the WSCP.
In combination with previous results from atypical dele-
tions, our observations that CLIP2 haploinsufficiency by
itself does not have apparent clinical consequences
support a pivotal role of GTF2I and GTF2IRD1 in theth CLIP2-Deletion Carriers
Male Carrier WSCP4,6–8
Age-Corrected
Scaled Score
Deviation from
Own Average***
Strengths and
Weaknesses
Strengths and
Weaknesses
9 2.29 weakness strength
12 þ0.71 strength
10 1.29 weakness
16 þ4.71 strength strength
12 þ0.71
9 2.29
11 0.29
9 1.6
9 1.6 weakness
11 þ0.4 weakness
14 þ3.4 strength
0 0.6
2 þ1.94
verbal and performance subtests are 11.29 and 10.06. Full results are available
ized in the legend of Table 1.
8, 2012
visual-spatial and cognitive aspects of theWBS phenotype.
Described deletions including these two genes are always
associated with a cognitive deficit. However, it cannot be
excluded that CLIP2 contributes to the clinical manifesta-
tion of the disorder when deleted in combination with
one or more additional genes. Defects in these and other
candidate genes will provide more insight in the geno-
type-phenotype correlation of the WBS microdeletion.Supplemental Data
Supplemental Data include full reports of the WAIS-III cognitive
profiling and the primers and probes used in this study and can
be found online at http://www.cell.com/AJHG/.Acknowledgments
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